AVTR - Avantor, Inc.

NYSE - NYSE Delayed Price. Currency in USD

Avantor, Inc.

Radnor Corporate Center
Building One Suite 200 100 Matsonford Road
Radnor, PA 19087
United States
610-386-1700
http://www.avantorsciences.com

SectorBasic Materials
IndustrySpecialty Chemicals
Full Time Employees12,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael StubblefieldPres, CEO & Director2.72MN/A1972
Mr. Thomas A. SzlosekExec. VP & CFO271.15kN/A1964
Mr. Bjorn HofmanExec. VP & COO2.91MN/A1970
Dr. Gerald Brophy Ph.D.Exec. VP of Biopharma Production357.58kN/A1966
Mr. Frederic VanderhaegenExec. VP of Europe214.35kN/A1967
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avantor, Inc. develops, customizes, manufactures, and supplies products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, and process chromatography resins and columns, as well as analytical sample prep, education, and microbiology and clinical trial kits. Its equipment and instrumentation products comprise filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and environment supplies. The company also provides onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Corporate Governance

Avantor, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.